Group

Cases

HSP-90α

(ng/ml)

TPSA

(ng/ml)

FPSA

(ng/ml)

Testosterone (ng/dl)

Prostate cancer

30

105.9 ± 23.5

5.9 ± 1.5

1.3 ± 0.6

426.5 ± 65.9

Prostatic hyperplasia

30

38.4 ± 8.9

2.5 ± 0.8

1.2 ± 0.5

756.5 ± 123.9

Control group

30

35.6 ± 7.7

2.3 ± 0.6

1.1 ± 0.3

762.9 ± 154.8

F

32.635

5.326

0.352

65.639

P

0.000

0.002

0.428

0.000